MyFinsight
Home
Compare
Blog
About
VitaNova Life Sciences Corp (VNOV)
VitaNova Life Sciences Corp (VNOV)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Unit: Dollar
Positive Cash Flow Breakdown
Accounts receivable
Accrued expenses and other curre...
Income tax payable
Negative Cash Flow Breakdown
Inventories
Net loss
Accounts payable
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-07-31
2026-04-30
2026-01-31
Net loss
-123,101
17,549
-54,853
Interest expenses
-
0
0
Share-based compensation
-
179,400
0
Accounts receivable
-409,872
-216,333
-262,509
Deferred tax assets
-
-16,038
-
Advance to vendor
-
0
-158,802
Bad debt expense
-
61,366
-
Prepayment
0
-
-
Other current assets
-
-7,074
4,583
Inventories
195,681
-24,823
86,189
Accounts payable
-86,008
99,835
108,978
Accrued expenses and other current liabilities
944
-2,992
21,066
Deferred revenue
0
-
-
Income tax payable
939
-159,037
-19,636
Net cash provided by operating activities
6,965
428,313
386,094
Interest paid
-
-
0
Proceeds from a related party
-
-
0
Repayment to related parties
-
0
-
Net cash used in financing activities
-
0
0
Net change in cash
6,965
428,313
386,094
Cash, beginning of period
1,597,217
1,168,904
782,810
Cash, end of period
1,604,182
1,597,217
1,168,904
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Accounts receivable
-$409,872
Accrued expenses and
other current...
$944
Income tax payable
$939
Net cash provided by
operating activities
$6,965
Canceled cashflow
$404,790
Net change in cash
$6,965
Inventories
$195,681
Net loss
-$123,101
Accounts payable
-$86,008
Buy us a coffee